🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Post-ablation Alcohol Impacts Arrhythmia Recurrence, Quality of Life and Cognition in AF

RecruitingNAAges 18 Years - 85 YearsAllTexas Cardiac Arrhythmia Research Foundation
NCT05510167 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Earlier studies have shown a dose-dependent relationship between alcohol intake and incident atrial fibrillation (AF) as well as a causal link with several risk factors for AF such as hypertension, obesity and sleep apnea. However, the effect of drinking (alcohol) on post-ablation outcome such as arrhythmia recurrence, quality of life (QoL) and cognitive function in AF patients is unclear. Therefore, we aim to find the answer for a very frequently asked question, "is it safe to continue drinking alcohol (at the pre-ablation level) following catheter ablation OR should the intake be reduced for better outcome?", in this randomized trial.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * AF patients that regularly consume \>5 alcoholic drink (\*12 g of pure alcohol/drink)/week * Paroxysmal or persistent AF * First catheter ablation History of alcohol-induced arrhythmia * Willing to sign the written informed consent Exclusion Criteria: * Binge drinkers (alcohol dependence) * Non-drinkers * LVEF \<35% * Psychiatric conditions * MoCA score ≤ 17 on Montreal Cognitive Assessment (MoCA) * Patients with established dementia * Medically unstable patients (acute/unstable or poorly controlled problems that would demand focused, relatively urgent or emergent medical attention) * Unwilling for alcohol-abstinence * Long-standing persistence AF * Patient under legal protection * Pregnancy
💊

What it tests

  • Study arm
📍

Where

1 site
Texas Cardiac Arrhythmia Institute, St. David's Medical Center
Austin, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy